| ROTIGOTINE n = 114 | |
| Age (years) |
|
| Mean | 69.84 |
| Range | 54 - 85 |
| Sex, n (%) |
|
| Female | 69 (60.52%) |
| Male | 45 (39.47%) |
| H & Y score, n (%) |
|
| I | 45 (39.47) |
| II | 28 (24.56) |
| III | 32 (28.07) |
| IV | 11 (9.64) |
| Duration of therapy (months) |
|
| Mean | 15.38 |
| Range | 1 - 48 |
| Monotherapy, n (%) | 33 (28.94) |
| Combination therapy, n (%) | 71 (62.28) |
| Rasagiline | 47 (41.22) |
| Amantadine | 15 (28.07) |
| Apomorphine | 5 (4.38) |
| Quetiapine | 4 (3.50) |
| L-dopa | 59 (51.75) |
| Daily dose (mg) |
|
| Mean (standar deviation) | 8.77 (2.77) |